These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16335853)

  • 21. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L
    Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
    [No Abstract]   [Full Text] [Related]  

  • 23. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.
    Brett S
    Crit Care; 2005 Feb; 9(1):45-50. PubMed ID: 15693983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of potent gastric acid inhibition.
    Carballo F
    Drugs; 2005; 65 Suppl 1():105-11. PubMed ID: 16335864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gastric acid conundrum in peptic ulcer.
    Dobrilla G; Steele A; Comberlato M; Amplatz S
    Ital J Gastroenterol; 1990 Jun; 22(3):142-6. PubMed ID: 2131944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N; Matsukawa J; Sakurai Y; Otake K
    Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological control of gastric acid secretion: molecular and cellular aspects.
    Mirossay L; Di Gioia Y; Chastre E; Emami S; Gespach C
    Biosci Rep; 1992 Oct; 12(5):319-68. PubMed ID: 1363275
    [No Abstract]   [Full Text] [Related]  

  • 31. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
    Miner P
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 33. New molecular targets for treatment of peptic ulcer disease.
    Lehmann F; Hildebrand P; Beglinger C
    Drugs; 2003; 63(17):1785-97. PubMed ID: 12921485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lansoprazole: a proton pump inhibitor.
    Garnett WR
    Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

  • 36. Acid suppression and ulcer healing: dichotomy, degree, and dilemma.
    Hunt RH
    Am J Gastroenterol; 1988 Sep; 83(9):964-6. PubMed ID: 2901221
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effects of gastric acid inhibitors].
    van de Ven LL
    Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1285. PubMed ID: 2755529
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlling acid secretion: individual variation in response.
    Walt RP
    Br J Clin Pract Suppl; 1994; 75():9-12; discussion 13. PubMed ID: 8060804
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors.
    Thjodleifsson B
    Drugs Aging; 2002; 19(12):911-27. PubMed ID: 12495367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.